JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M201005200 on February 8, 2002

J. Biol. Chem., Vol. 277, Issue 17, 15013-15020, April 26, 2002
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/17/15013    most recent
M201005200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schüttelkopf, A. W.
Right arrow Articles by Hunter, W. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schüttelkopf, A. W.
Right arrow Articles by Hunter, W. N.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Passive Acquisition of Ligand by the MopII Molbindin from Clostridium pasteurianum

STRUCTURES OF APO AND OXYANION-BOUND FORMS*

Alexander W. SchüttelkopfDagger, Jennifer A. HarrisonDagger, David H. Boxer, and William N. Hunter§

From the The Wellcome Trust Biocentre, Division of Biological Chemistry and Molecular Microbiology, School of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom

Received for publication, January 30, 2002, and in revised form, February 6, 2002

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

MopII from Clostridium pasteurianum is a molbindin family member. These proteins may serve as intracellular storage facilities for molybdate, which they bind with high specificity. High resolution structures of MopII in a number of states, including the first structure of an apo-molbindin, together with calorimetric data, allow us to describe ligand binding and provide support for the proposed storage function of the protein. MopII assembles as a trimer of dimers and binds eight oxyanions at two types of binding sites located at intersubunit interfaces. Two type 1 sites are on the molecular 3-fold axis and three pairs of type 2 sites occur on the molecular 2-fold axes. The hexamer is largely unaffected by the binding of ligand. Molybdate is admitted to the otherwise inaccessible type 2 binding sites by the movement of the N-terminal residues of each protein chain. This contrasts with the structurally related molybdate-dependent transcriptional regulator ModE, which undergoes extensive conformational rearrangements on ligand binding. Despite similarities between the binding sites of ModE and the type 2 sites of MopII the molbindin has a significantly reduced ligand affinity, due, in part, to the high density of negative charges at the center of the hexamer. In the absence of ligand this effects the movement of an important lysine side chain, thereby partially inactivating the binding sites. The differences are consistent with a biological role in molybdate storage/buffering.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

Mop1 domains, which occur in a variety of bacterial and archeal proteins, specifically bind molybdate. The simplest mop-containing proteins are the so-called molbindins (1, 2), consisting entirely of either one or two mop domains. The physiological role of these proteins is unclear, although they have been implicated in molybdate storage and homeostasis (3). Other mop-containing proteins are ModC, a component of the high affinity ABC-type molybdate transporter (4) and ModE, the molybdate-dependent transcriptional regulator (5, 6).

ModE-like proteins occur in a number of organisms such as Escherichia coli, where this protein mediates both the molybdate-dependent transcriptional repression of the modABCD operon (MoO<UP><SUB>4</SUB><SUP>2−</SUP></UP> transport (7-9)) and the molybdate-dependent activation of the moaABCDE operon (molybdopterin biosynthesis (10)). ModE also influences the expression of molybdoenzymes such as dimethyl sulfoxide reductase (6) and nitrate reductase A (11). Functional ModE is a homodimeric protein, which folds into two distinct domains, an N-terminal DNA-binding domain and a C-terminal molybdate-binding domain. The latter consists of four mop domains (two from each chain).

The structure of the mono-mop molbindin from Sporomusa ovata in complex with tungstate (12) shows Mop subunits assembled into a trimer of dimers forming eight oxyanion binding sites. A similar arrangement was found for ModG from Azotobacter vinelandii, a di-mop molbindin. The crystal structure of this protein shows a trimeric arrangement where one ModG molecule takes the place of each Mop dimer (13). The structures of complete Escherichia coli ModE in its apo form (14) as well as its ligand-bound C-terminal domain (2) have been determined. The protein binds two molybdate anions per dimer. The quaternary structure adopted by the four mop domains of the dimer superimposes on two Mop dimers or two di-mops from the molbindins.

The nitrogen-fixing bacterium Clostridium pasteurianum possesses three distinct genes encoding molbindins (15); the three proteins, Mop I through III, are approx 7 kDa in size and show a high degree of amino acid sequence conservation (>86% identity). They consist of a single mop domain and thus belong to the mono-mop molbindin family.

We report a number of high resolution crystal structures for C. pasteurianum MopII: two different structures of the apoprotein (Apo1 and Apo2), one structure of the tungstate complex, and two structures of Mop-molybdate complexes (Moo1 and Moo2, named after the Protein Data Bank name for molybdate). The apoprotein and the ligand-bound protein crystallized in different monoclinic crystal forms, both with six Mop molecules per asymmetric unit. In the case of the apoprotein they form a complete hexamer, whereas the ligand-bound structures contain two separate Mop trimers, which are complemented to hexamers by crystallographic symmetry. The structures provide the first view of an apo-molbindin and allow us to characterize the mechanism by which Mop acquires ligands and to compare this mechanism to that described for ModE (2). Calorimetric studies complement the crystallographic analysis, further characterizing molybdate binding to Mop and enabling us to compare ligand affinities with those of ModE.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

Crystallization, Data Collection, Structure Solution, and Refinement-- The cloning, expression, and purification of MopII as well as crystallization conditions and data collection procedures for the tungstate, Moo1, and Apo1 complexes are as previously described (16). After it was determined that the Moo1 structure contained only partially loaded binding sites, more crystals were grown, but this time with the addition of 1 µl of 8 mM Na2MoO4 directly to the drop. Data from these crystals were collected in-house using a Rigaku RU-200 rotating anode x-ray source (Cu Kalpha , lambda  = 1.5418 Å) and an R-Axis IV image plate detector. The resulting data set (Moo2) was processed and scaled to 2.4 Å using DENZO/SCALEPACK (17).

In the hope of improving the resolution limit of the apo-structure (Apo1: 1.8 Å) a second data set was collected in-house from a crystal grown under the same conditions as described before (16). The experimental setup, scaling, and processing were as for the Moo2 data; the high resolution limit for the new data set (Apo2) is 1.5 Å.

Phases were obtained by single isomorphous replacement with anomalous scattering (SIRAS) using the tungsten anomalous signal from the tungstate data and the isomorphous differences between the tungstate and the Moo1 data. We note that the partial occupancy of the MoO<UP><SUB>4</SUB><SUP>2−</SUP></UP> sites was fortuitous for the phasing calculations. SOLVE (18) found and refined all eight oxyanion sites, producing phases with a figure of merit (FOM)2 of 0.47-2.0 Å. Density modification using RESOLVE (19) improved the FOM to 0.72. The resulting map was used with ARP/wARP in warpNtrace mode (20, 21) to obtain an initial model containing 371 of the 408 expected amino acid residues. Cycles of model building using O (22), water placement with ARP/wARP, and refinement using CNS (23) and/or REFMAC (20, 24) led to the final refined structure. The other data sets were solved by molecular replacement with the refined tungstate structure using AMoRe (25) and refined in a similar fashion. For a summary of data collection, processing, and refinement statistics see Table I.

Figs. 1A and 2 through 5 were generated with MOLSCRIPT (26) and Raster3D (27). Fig. 1B was produced using ALSCRIPT (28). Cavity volumes were calculated with the program VOIDOO (29) using default parameters.

MALDI-TOF Mass Spectrometry-- Experiments were carried out on a Voyager MALDI-TOF (matrix-assisted laser desorption ionization time-of-flight) mass spectrometer (Amersham Biosciences, Inc.) using a sinapinic acid matrix. MopII was used as a 1 mg/ml solution in 50 mM Tris/HCl, pH 8.0, with and without addition of a 5-fold molar excess of Na2MoO4.

Isothermal Titration Calorimetry (ITC) Analysis-- Calorimetric measurements were performed using a VP-ITC instrument (Microcal, Inc.). All experiments were carried out at 25 °C. The concentration of the MopII solutions was determined by the Bradford method (30), a necessity due to the absence of a (UV) chromophore in the protein. A 100 µM solution of MopII in 50 mM Tris/HCl, pH 8.0, in the calorimetric cell was titrated with sodium molybdate (concentrations between 0.5 and 1.5 mM in the injection syringe) dissolved in the same buffer. The syringe was refilled with titrate during the measurements. As a dilution correction a titration of buffer with sodium molybdate solution in buffer was carried out. After integration, the determined heat of dilution was subtracted from the heat of reaction. The data were integrated and analyzed using Origin 5 (Microcal, Inc.).

Coordinates-- The atomic coordinates and structure factors have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (www.rcsb.org). Accession codes are given in Table I.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Data collection, processing, refinement, and model statistics
Numbers in parentheses refer to the highest resolution shell of about 0.1 Å width.


    RESULTS AND DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

Overall Structure-- The 68-amino acid Mop polypeptide consists predominantly of beta -strands (52% of the residues in six strands), most of which (beta 2-beta 5) form a twisted antiparallel beta -sheet. There is also a short alpha -helix (10% of residues) between beta 4 and beta 5 and two 310-helical segments (eta 1 and eta 2; 8% of residues) between beta 3 and beta 4 and between beta 5 and beta 6, respectively (Fig. 1, A and B). In all crystal structures six Mop subunits form a compact hexamer with 32-point group symmetry and a diameter of about 60 Å (Fig. 2, A and B). An area of approximately 17,400 Å2 (approx 55% of the accessible monomer surface) is buried upon oligomerization. The previous structures of S. ovata Mop and ModG show a similar quaternary structure.


View larger version (49K):
[in this window]
[in a new window]
 
Fig. 1.   A, schematic representation of a single C. pasteurianum MopII molecule. Secondary structure elements are shown in blue (beta -strands), red (alpha -helix), or yellow (310-helices) and labeled appropriately. All figures represent the tungstate complex unless noted otherwise. The three tungstate ions interacting with this subunit are shown as CPK models and labeled T1 and T2 for type 1 and type 2 sites, respectively (see text). B, sequence alignment of selected mop domains with the assigned secondary structure elements for MopII. Residues shaded black, dark gray, and light gray are identical in all sequences, in 80% and in 60% of sequences, respectively. Colored shading indicates residues involved in type 1 site binding (blue), type 2 site binding (yellow), and the central chamber (red). For proteins with more than one mop per chain, mop domains are numbered from the N terminus, and the numbers are given in square brackets. H. influenzae = Hemophilus influenzae, Rh. loti = Rhizobium loti.


View larger version (72K):
[in this window]
[in a new window]
 
Fig. 2.   A, stereo view of the complete hexameric structure. Tungstate ions are shown as CPK models, and the dotted gray line represents the molecular 3-fold symmetry axis. B, the hexamer seen down the 3-fold axis. C, subunit arrangement: The hexameric molecule can be abstracted as a (distorted) trigonal antiprism with the six subunits (represented as spheres and labeled by chain name) occupying its corners. The edges of this antiprism represent the intersubunit interfaces; they are colored by interface type.

The Mop hexamer is observed by mass spectrometry and by native polyacrylamide gel electrophoresis (data not shown). Moreover, considering that all ligand binding sites are formed through the interaction of two or more subunits, it is likely that the hexamer represents the functional unit. We are furthermore confident that the reported hexameric apo-structures are physiologically meaningful, because the mass spectra show the hexamer peak even in the absence of ligand.

For the following discussion the six chains have been assigned chain identifiers A through F as shown in Fig. 2C. We use these chain names to differentiate between the two trimers and more generally the two poles of the molecule (ABC and DEF). In the case of the two apo-structures, the chain names used are identical to those in the deposited coordinate sets. The crystallographic symmetry in the ligand-bound structures means that the chain identifiers A-F as used here are actually chains A, B, C, A*, B*, C* or D*, E*, F*, D, E, F (where X* is symmetry-related to X).

The hexamer possesses three unique intersubunit interfaces (Fig. 2C), one between subunits from the same trimer (yellow edges in Fig. 2C) and two interfaces between subunits from opposite trimers (both with internal 2-fold symmetry; red and green edges). The most extensive interaction occurs at the "red" interface, which contributes ~3 × 2950 Å2 of the buried accessible surface and involves 29 residues on each side. The main feature of this interface is the interaction between beta 5 from either subunit and beta 6 from the other subunit. This results in the extension of the central beta -sheets to two Greek-key beta -barrels, which display structural similarity to the oligonucleotide/oligosaccharide binding fold (31). The interaction between beta 5 and beta 6' (primes are used to denote a different chain) accounts for eight of the sixteen direct hydrogen bonds formed across the red interface, the remaining hydrogen bonds are formed between strand beta 4 and side chains from beta 2' as well as backbone atoms from eta 2'. In addition to these direct interactions, this interface also includes 16 water-bridged hydrogen-bonding contacts.

Contacts across the green interface (about 3 × 1180 Å2 of buried surface) are formed by 13 residues from helix alpha 1, strands beta 1 and beta 4, and the 310-helix eta 2 on either side; interactions include a salt bridge between Arg6 and Glu46' and 10 direct hydrogen bonds. Six of the eight oxyanion binding sites are formed at this interface (see below).

The yellow interface buries 6 × 1040 Å2 of solvent-accessible surface area with about 70% of this surface being hydrophobic in nature. Its principal feature is the antiparallel alignment of beta 6 with beta 1', which is stabilized by three direct hydrogen bonds and two bridging waters and further extends the central beta -sheet. Strands beta 3 and beta 4 as well as eta 2 from both sides participate in further contacts, providing three more direct hydrogen bonds.

With the exception of Apo2 (see below) the backbone conformations are remarkably similar between subunits both within any structure (root mean square deviation (r.m.s.d.) values for Calpha atoms after pairwise alignment less than 0.4 Å) and between different structures (r.m.s.d. values for Calpha atoms less than 0.5 Å). In the case of the two apo-structures, an even higher degree of similarity is observed between subunits from the same trimer (r.m.s.d. less than 0.08 Å). The observed similarity is not an artifact of refinement, because only weak restraints on non-crystallographic symmetry were applied or, in the case of Apo2, none at all.

The Ligand Binding Sites-- C. pasteurianum MopII possesses eight oxyanion binding sites per hexamer, all of which make use of the oligomeric assembly: two sites lie on the molecular 3-fold axis at the centers of the two trimers, whereas the remaining six are located at the green interfaces (Fig. 2, A and B). In accordance with Wagner et al. (12) these anion binding positions are referred to as type 1 and type 2 sites, respectively.

Type 1 sites are formed by the bend between beta 2 and beta 3 from three Mop chains related by the molecular 3-fold axis (Figs. 1A, 2, and 3A). The symmetry of the binding site is mirrored by the ligand binding mode: The central metal atom and one of the oxygen atoms lie on the 3-fold axis. This axial oxygen points into the hexamer, whereas the other three oxygens face outwards and each one toward a different subunit (cf. Fig. 2B). The bound oxyanion forms twelve hydrogen bonds with the protein, three of them at the axial oxygen, which is contacted by the side-chain hydroxyl of Thr22 from all three Mop chains. The other oxygen atoms each accept three hydrogen bonds from the backbone amides of Val20, Val21, and Thr22 of one protein molecule, although the latter is relatively weak at an average distance of 3.3 Å. It is noteworthy that no positively charged groups are involved in binding of the oxyanion at this site, in fact no such groups exist within a radius of 9 Å from the oxyanion. With the exception of a hydrogen bond from the Thr22 side chain, interactions with the ligand are limited to the protein backbone. The lack of sequence conservation for the residues involved (Fig. 1B) is consistent with this observation.

Type 2 sites occur in pairs at the three green interfaces and are created by beta 1 as well as eta 2 from one subunit and the alpha 1' helix from the other subunit. The protein donates eight hydrogen bonds to the ligand, five from beta 1/eta 2, and three from alpha 1'. Two of the ligand oxygens accept only one hydrogen bond (from the Ser4 hydroxyl and the Lys60 amine, respectively), the third oxygen forms the remaining three hydrogen bonds with the same subunit (with the Arg6 backbone amide and both the amide and the side chain hydroxyl from Ser61). The fourth oxygen accepts all three hydrogen bonds from the other subunit (amide and hydroxyl of Ser40' and hydroxyl of Ser43' from consecutive turns of the helix, Fig. 3B). In this case partial compensation for the negative charge of the ligand is afforded by the side chain of Lys60. Most of the residues participating in the formation of type 2 sites are at least functionally conserved, as should be expected given that most of them contact the oxyanion with their side chains. Only Ser43 and Ser61 are replaced by alanine or glycine in some molbindins (Fig. 1B). Arg6 is conserved in almost all mop proteins, despite the fact that its side chain does not contribute to molybdate binding, instead forming an important salt bridge with Glu46' as described above.


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 3.   Representative binding sites (tungstate-occupied). A, type 1 site; B, type 2 site. Nitrogen and oxygen atoms are blue and red, respectively. Protein residues are colored by chain as in Fig. 2 and labeled by single-letter amino acid code and residue number. Primes are used to differentiate between polypeptide chains. Black dotted lines symbolize hydrogen bonds. In B residue Ala5 is semi-transparent, and the side chain of residue Arg6 has been omitted for clarity.

Binding Sites in the Apo-structures-- Aside from a few exceptions that will be described, the similarity in backbone conformation between the various MopII structures can be extended to the side-chain conformations, with subunit-subunit alignments typically resulting in r.m.s.d. values below 0.7 Å for approx 480 atoms. Most of the ligand binding sites in the apo-structures are also similar to the corresponding ligand-filled sites. In the absence of ligand, the positions of its oxygen atoms are populated by solvent atoms.

The best correspondence between apo- and ligand-bound structures is observed for type 1 sites (Fig. 4A), alignment of Apo1 with the tungstate complex puts solvent molecules within 0.7 Å of all tungstate oxygens. However, a noticeable difference lies in the position of Val20: Its side chains, which limit access to the site from the bulk solvent, move slightly outwards in the apo forms compared with ligand-bound structures, thereby widening the access bore from an average diameter of 5.6 Å (ligand-bound) to ~7.5 Å (apo) and thus facilitating ligand access. The slightly increased space requirements of the solvent structure compared with the oxyanion may account for this.


View larger version (32K):
[in this window]
[in a new window]
 
Fig. 4.   Ligand binding sites in the apo-structures and Moo1. Conventions as described for Fig. 3. Cyan and yellow spheres represent water atoms and chloride ions, respectively. The yellow tetrahedra denote the positions of ligand oxygen atoms in the aligned tungstate structure. A, representative type 1 site from Apo1. B, representative type 2 site from the DEF half of Apo1. C, representative type 2 site from the ABC half of Apo1. D, representative type 1 site from Moo1; the molybdate is shown as a ball-and-stick model.

The three type 2 sites located closer toward the DEF pole of Apo1 are also structurally similar to their liganded counterparts (Fig. 4B). One minor difference concerns the side chain of Ser61, which appears in two alternate conformations in Apo1. Again ligand oxygen equivalent positions are occupied by solvent molecules. Only the solvent molecule hydrogen-bonding to the Lys60 side chain is about 1.1 Å from the ideal position, which allows it to form an additional hydrogen bond to the hydroxyl of Ser61 in its alternate conformation (asterisk in Fig. 4B). A more prominent difference is observed for the type 2 sites closer to the ABC poles of both apo-structures (Fig. 4C): The side chain of Lys60 adopts a completely different conformation pointing away from the binding site. Subsequently, the solvent molecule that accepted a hydrogen bond from Lys60 in the other sites has moved even further (up to 2.0 Å from the closest aligned oxyanion oxo position, not shown).

The largest difference from the ligand-bound structures can be observed in the DEF half of Apo2 (Fig. 5): The N-terminal six residues of chains A, B, and C (chain B in Fig. 5) move up to 6 Å outwards, thereby partly exposing the type 2 site underneath. Concomitantly minor movements of surrounding residues, including the C terminus of a neighboring chain (chain A in Fig. 5) and residues 46-48 from another chain (chain D in Fig. 5), can be observed. This more open conformation demonstrates how the otherwise solvent-inaccessible type 2 sites may acquire ligand molecules.


View larger version (57K):
[in this window]
[in a new window]
 
Fig. 5.   Comparison of type 2 sites from the DEF half of the tungstate complex (top) and Apo2 (bottom). The colors used are similar to those in the previous figures. Protein residues are shown as CPK representations and are labeled with the one-letter amino acid code, the residue number, and the chain name. In the apo-structure the position of the oxyanion from the superimposed tungstate structure is shown as semi-transparent spheres.

Ligand Binding in Moo1-- Initial refinement of the Moo1 complex resulted in the eight molybdenum atoms having unexpectedly high temperature factors compared with their oxo ligands. Given the solvent arrangement in the apo-structures, coupled with the absence of lower-mass oxyanions from the crystallization conditions, we interpret the observed electron density as resulting from partially molybdate-occupied sites. The superposition of actual oxyanion oxygens and solvent molecules (both with partial occupancy) mimics fully occupied oxo ligands. The occupancies for the molybdenum atoms were reduced to 0.5 and 0.25 for type 1 and type 2 sites, respectively, which brought the temperature factors more in line with those of the surrounding protein atoms. A further indication of the partial ligand occupancy in this structure is the observation that the side chain of Lys60 exhibits a dual conformation in two of the protein chains, pointing both toward the nearby type 2 site (as in the fully loaded structures) and toward the center of the oligomer as in the apo-subunits. The partially occupied binding sites in Moo1 also underline the lack of structural differences between apo- and ligand-bound Mop.

In addition, the oxyanions in the two type 1 sites of Moo1 adopt a different orientation from the one seen in the other loaded structures: The ligand is again oriented along the 3-fold axis, only now the axial oxygen points outwards. The three equatorial oxygens are in approximately the same position as in the other structures (Fig. 4D). The hydrogen bond donors and the number of hydrogen bonds are the same for both orientations, differing only in relative strength. While in the tungstate and Moo2 structures the interaction with the backbone amide of Thr22 is weakest, in Moo1 the most distant interaction is with the Val20 amide (distances about 3.5 Å). It is noteworthy that, similar to the other ligand oxygens, the new axial oxygen position is occupied by a water molecule in some of the apo-trimers, suggesting that this binding mode is not fundamentally disadvantaged, even though the temperature factors for this water is about double that of its neighbors.

Thermodynamics of Ligand Binding-- To better establish the properties of the different binding sites and to gain insight into the possible function of molbindins, we characterized molybdate binding by isothermal titration calorimetry (ITC (32, 33)) (Fig. 6). Although we cannot exclude the possibility of cooperativity between some anion binding sites, we find a reasonable fit for our data using a model with two types of independent sites, which is in accordance with the structural evidence. The results are summarized in Table II.


View larger version (22K):
[in this window]
[in a new window]
 
Fig. 6.   ITC titration data describing the binding of molybdate to C. pasteurianum MopII. Differential power signal recorded in a representative experiment (top) and integrated data (dots) and fitted curve (solid line) from the same experiment (bottom).

                              
View this table:
[in this window]
[in a new window]
 
Table II
Thermodynamic data for molybdate binding to C. pasteurianum MopII
Ka, association constant; n, number of sites per Mop molecule; Delta H, heat of binding; Delta G, free energy of binding; Delta S, entropy of binding. Errors on Ka, Delta H, and n are standard deviations from triplicate experiments; those on Delta G and Delta S are propagated errors.

The two sets of site parameters were assigned to type 1 and type 2 sites based on the refined values for n (number of sites per molecule); even though at 0.61 and 1.58 both experimental values are larger than expected, their ratio (n1/n2 = 0.39) correlates well with the expected value of 0.33 (for one-third type 1 site and one-type 2 site per Mop molecule). The single largest error influencing the absolute values for n is likely to stem from the estimate of protein concentration. Because this error is compensated for by n it should not affect the quality of the remaining results.

The association constants Ka show that type 1 sites have a more than one order of magnitude higher affinity for molybdate than type 2 sites. This corresponds to the relative binding affinities established independently by the different site occupancies in the Moo1 structure.

The small changes between unbound and bound state, in terms of van der Waals and hydrogen bonding interactions, and the lack of strong electrostatic interactions in type 1 sites, suggest that binding enthalpy should be small (Delta H approx  0). Thus the main driving force for binding is the entropic gain (Delta S > 0) from the displacement of four ordered waters by one ligand molecule; this is corroborated by the experimental data. For type 2 sites the situation is similar, but as ligand binding localizes both the side chains of Lys60 and Ser61 and the N-terminal flap, Delta S is reduced. At the same time Delta H becomes more negative due to the electrostatic interaction between the ligand and the side chain of Lys60, resulting in a slightly larger enthalpic contribution to ligand binding.

The only other mop protein for which binding constants are published is ModE from E. coli (5), which binds molybdate with a Ka of ~1.3 × 106 M-1 in its two type 2 sites. The lower affinity determined for the type 2 sites of MopII (Ka approx  2.1 × 105 M-1) is compatible with a proposed intracellular role as a passive molybdate storage facility. In the absence of a specific energy-driven ligand extraction mechanism, a storage protein must bind less strongly than the proteins that utilize the stored ligand.

The Central Chamber-- At the center of the Mop hexamer there is an extensive solvent-filled chamber with a volume of 472 Å2 (measured for the tungstate structure). The wall of the cavity is lined with (partially) negatively charged entities, in particular the side chains of Asp63 and the backbone carbonyls of Lys60 and Thr62 from all six chains. Based on their coordination, some of the solvent molecules in the chamber were assigned to be Mg2+, Ca2+, or Na+ ions.

The high local concentration of negative charges is especially remarkable in the context of the conformational change of the Lys60 side chain in the apo-structures. The side chain, which otherwise forms part of a type 2 binding site, positions its amino group in the central plane between the two trimers and within 3.5 Å of two Asp63 carboxylates. This conformation is adopted by half of the apo-Mop subunits in the Apo1 and Apo2 structures, the maximum number possible without clashes between lysines from opposite trimers. Given that this is the preferred conformation in apo-structures and that the absence of Lys60 is likely detrimental to type 2 site binding, this observation may in part explain the reduced ligand affinity of the MopII type 2 sites compared with ModE, which, as explained above, is essential for the storage function of Mop. Additionally, the central chamber may furnish a place for storing counterions and thus provide protection from unrestricted charge separation; the presence of cations in the chamber would then partly counteract the affinity-reducing effect. Asp63 is functionally conserved (as aspartate or glutamate) in practically all molbindins (Fig. 1B).

Comparison with Mop from S. ovata-- C. pasteurianum MopII and S. ovata Mop are relatively similar in amino acid sequence (37% sequence identity, see Fig. 1B). It should be noted, however, that the sequence of the S. ovata Mop has been derived from the crystal structure (12) and may harbor inaccuracies due to disordered or ambiguous electron density. The two proteins exhibit identical subunit arrangement and similar backbone conformations (r.m.s.d. about 0.7 Å for 396 superimposable Calpha atoms); the only difference of note is the deletion of Gly31 in the S. ovata structure.

The oxyanion binding sites are also similar; differences of note have been listed in Table III. The ligands bound to the type 1 sites of S. ovata Mop are in a conformation comparable to that seen in the Moo1 structure (and were also assigned a reduced occupancy). It is possible that for S. ovata Mop the Moo1-like binding mode is actually preferred, because the replacement of Thr22 with a methionine may have a greater deleterious effect on the normal binding mode than on the Moo1-like mode. The central chamber is present in the S. ovata structure, but it is subdivided into several smaller cavities due to the replacement of Asp63 with a glutamate.

                              
View this table:
[in this window]
[in a new window]
 
Table III
Comparison of ligand binding sites from different mop proteins
Amino acid changes (indicated by right-arrow) are only listed if they affect the hydrogen bonding pattern. For ModG the sites located in the N-terminal and C-terminal trimers are listed separately (labeled as [N] and [C]).

Comparison with A. vinelandii ModG-- The di-mop molbindin ModG from A. vinelandii is a 142-amino acid protein consisting of a tandem repeat of mop domains. A crystal structure of molybdate-loaded ModG (13) shows that ModG trimerizes to a hexa-mop arrangement similar to that of the other molbindins: The 402 Calpha atoms of ligand-bound C. pasteurianum Mop can be superimposed with an r.m.s.d. of below 0.85 Å. Each ModG molecule corresponds to a pair of Mop chains interacting across the red interface with the addition of a five amino acid loop between the C terminus of one Mop and the N terminus of the other. This connection introduces a polarity into the hexa-mop arrangement, producing a C-terminal trimer and an N-terminal trimer (the three ModG chains associate in a head-to-head fashion). All ligands are still bound at intersubunit interfaces.

Again the ligand binding sites are similar to those found in Mop (see Table III), and the ligand orientation is almost identical to that seen in the fully oxyanion-loaded Mop structures for both types of sites. Delarbre et al. (13) describe a hydrogen bonding network between type 1 and type 2 sites in ModG and remark on the possible implications for cooperative ligand binding. No such network is observed in the MopII structures.

It is unlikely that the type 2 site loading mode proposed for Mop is also applicable to ModG, because half of the Mop N termini are now in the middle of the polypeptide chain. Still the loop between the two domains may be flexible enough to allow the required rearrangement. ModG is one of the few molbindins that lacks the conserved aspartate/glutamate of the central chamber. In its place there is an asparagine or a tryptophan.

Comparison with E. coli ModE-- ModE, like ModG, contains a tandem repeat of mop domains, which in this case is attached to the C terminus of a winged helix-turn-helix DNA-binding domain. The main difference between ModE and the molbindins is that ModE is a dimer, not a trimer. However, its four mop domains superimpose reasonably well with appropriately chosen chains from the C. pasteurianum Mop hexamer (r.m.s.d. 1.58 Å for 258 Calpha atoms using the tungstate-bound ModE di-mop structure (2)). The ModE mop tetramer cannot offer any type 1 ligand binding sites and can provide only two type 2 sites between the N-terminal mop domains from both chains. The ligand binding mode is similar to that of the other mop proteins (see Table III for details).

As in the case of ModG the N termini of the individual mop domains of ModE are unable to move freely, thus ligand acquisition cannot occur by the passive mechanism proposed for Mop. Instead, the greater flexibility of ModE allows the apoprotein to adopt a more open structure with binding sites that are accessible from the bulk solvent. Ligand binding results in an extensive conformational change involving both inter- and intradomain movements, with the protein chomping on the ligand (2). The more extensive rearrangements seen in ModE might be beneficial for its functioning as a molybdate-dependent transcriptional regulator, possibly transmitting the signal of molybdate/tungstate binding to the DNA-binding domain. In light of the sequence similarity among mop domains, it is remarkable how the basic theme of molybdate binding is modulated to fit the requirements of particular proteins. On the one hand there are signaling proteins like ModE with high sensitivity and low binding capacity, and on the other hand there is Mop as a storage protein with lower sensitivity but high molybdate binding capacity.

    ACKNOWLEDGEMENTS

We thank the Biological and Biotechnology Sciences Research Council, UK and the Wellcome Trust for funding and the staff at station PX9.6 of the SRS at Daresbury Laboratory for their support. We also thank C. Bond, A. Cooper, D. Gourley, and D. Lamont for their help and useful discussions.

    FOOTNOTES

* This work was supported by the Biological and Biotechnology Sciences Research Council, UK and the Wellcome Trust.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger Both authors contributed equally to this work.

§ To whom correspondence should be addressed. Tel.: 44-1382-345-745; Fax: 44-1382-345-764; E-mail: w.n.hunter@dundee.ac.uk.

Published, JBC Papers in Press, February 8, 2002, DOI 10.1074/jbc.M201005200

1 Mono-mop molbindins are generally known as Mop proteins; we shall use "Mop" (uppercase) to refer to Mop proteins and "mop" (lowercase) for mop domains.

    ABBREVIATIONS

The abbreviations used are: FOM, figure of merit; r.m.s.d., root-mean-square deviation; ITC, isothermal titration calorimetry; MALDI-TOF, matrix-assisted laser desorption ionization time-of-flight.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

1. Lawson, D. M., Williams, C. E., White, D. J., Choay, A. P., Mitchenall, L. A., and Pau, R. N. (1997) J. Chem. Soc. Dalton Trans. 21, 3981-3984[CrossRef]
2. Gourley, D. G., Schüttelkopf, A. W., Anderson, L. A., Price, N. C., Boxer, D. H., and Hunter, W. N. (2001) J. Biol. Chem. 276, 20641-20647[Abstract/Free Full Text]
3. Grunden, A. M., and Shanmugam, K. T. (1997) Arch. Microbiol. 168, 345-354[CrossRef][Medline] [Order article via Infotrieve]
4. Pau, R. N., Klipp, W., and Leimkuhler, S. (1997) in Iron and Related Transition Metals in Microbial Metabolism (Winkelmann, G. , and Carrano, C. J., eds) , pp. 217-234, Harwood Academic Publishers, London, UK
5. Anderson, L. A., Palmer, T., Price, N. C., Bornemann, S., Boxer, D. H., and Pau, R. N. (1997) Eur. J. Biochem. 246, 119-126[Medline] [Order article via Infotrieve]
6. McNicholas, P. M., Mazzotta, M. M., Rech, S. A., and Gunsalus, R. P. (1998) J. Bacteriol. 180, 4638-4643[Abstract/Free Full Text]
7. Grunden, A. M., Self, W. T., Villain, M., Blalock, J. E., and Shanmugam, K. T. (1999) J. Biol. Chem. 274, 24308-24315[Abstract/Free Full Text]
8. Rech, S., Deppenmeier, U., and Gunsalus, R. P. (1995) J. Bacteriol. 177, 1023-1029[Abstract/Free Full Text]
9. Walkenhorst, H. M., Hemschemeier, S. K., and Eichenlaub, R. (1995) Microbiol. Res. 150, 347-361[Medline] [Order article via Infotrieve]
10. Anderson, L. A., McNairn, E., Leubke, T., Pau, R. N., and Boxer, D. H. (2000) J. Bacteriol. 182, 7035-7043[Abstract/Free Full Text]
11. Self, W. T., Grunden, A. M., Hasona, A., and Shanmugam, K. T. (1999) Microbiology 145, 41-55[Abstract]
12. Wagner, U. G., Stupperich, E., and Kratky, C. (2000) Structure 8, 1127-1136[Medline] [Order article via Infotrieve]
13. Delarbre, L., Stevenson, C. E. M., White, D. J., Mitchenall, L. A., Pau, R. N., and Lawson, D. M. (2001) J. Mol. Biol. 308, 1063-1079[CrossRef][Medline] [Order article via Infotrieve]
14. Hall, D. R., Gourley, D. G., Leonard, G. A., Duke, E. M. H., Anderson, L. A., Boxer, D. H., and Hunter, W. N. (1999) EMBO J. 18, 1435-1446[CrossRef][Medline] [Order article via Infotrieve]
15. Hinton, S. M., and Freyer, G. (1986) Nucleic Acids Res. 14, 9371-9380[Abstract/Free Full Text]
16. Harrison, J. A., Schüttelkopf, A. W., Boxer, D. H., and Hunter, W. N. (2001) Acta Crystallogr. Sect. D Biol. Crystallogr. 57, 1715-1717[CrossRef][Medline] [Order article via Infotrieve]
17. Otwinowski, Z., and Minor, V. (1997) Methods Enzymol. 276, 307-326
18. Terwilliger, T. C., and Berendzen, J. (1999) Acta Crystallogr. Sect. D Biol. Crystallogr. 55, 849-861[CrossRef][Medline] [Order article via Infotrieve]
19. Terwilliger, T. C. (2000) Acta Crystallogr. Sect. D Biol. Crystallogr. 56, 965-972[CrossRef][Medline] [Order article via Infotrieve]
20. Collaborative Computational Project Number 4. (1994) Acta Crystallogr. Sect. D Biol. Crystallogr. 50, 760-763[CrossRef][Medline] [Order article via Infotrieve]
21. Perrakis, A., Morris, R., and Lamzin, V. S. (1999) Nat. Struct. Biol. 6, 458-463[CrossRef][Medline] [Order article via Infotrieve]
22. Jones, T. A., Zou, J. Y., Cowan, S. W., and Kjeldgaard, M. (1991) Acta Crystallogr. Sect. D Biol. Crystallogr. 47, 110-119
23. Brünger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P., Grosse-Kunstleve, R. W., Jiang, J. S., Kuszewski, J., Nilges, M., Pannu, N. S., Read, R. J., Rice, L. M., Simonson, T., and Warren, G. L. (1998) Acta Crystallogr. Sect. D Biol. Crystallogr. 54, 905-921[CrossRef][Medline] [Order article via Infotrieve]
24. Murshudov, G. N., Vagin, A. A., and Dodson, E. J. (1997) Acta Crystallogr. Sect. D Biol. Crystallogr. 53, 240-255[CrossRef][Medline] [Order article via Infotrieve]
25. Navaza, J. (1994) Acta Crystallogr. Sect. A 50, 157-163[CrossRef]
26. Kraulis, P. J. (1991) J. Appl. Crystallogr. 24, 946-950[CrossRef]
27. Merrit, E. A., and Bacon, D. J. (1997) Methods Enzymol. 277, 505-524[Medline] [Order article via Infotrieve]
28. Barton, G. J. (1993) Protein Eng. 6, 37-40[Free Full Text]
29. Kleywegt, G. J., and Jones, T. A. (1994) Acta Crystallogr. Sect. D Biol. Crystallogr. 50, 178-185[CrossRef][Medline] [Order article via Infotrieve]
30. Bradford, M. (1976) Anal. Biochem. 72, 248-254[CrossRef][Medline] [Order article via Infotrieve]
31. Murzin, A. G. (1993) EMBO J. 12, 861-867[Medline] [Order article via Infotrieve]
32. Wiseman, T., Williston, S., Brandts, J. F., and Lin, L. N. (1989) Anal. Biochem. 179, 131-137[CrossRef][Medline] [Order article via Infotrieve]
33. Cooper, A., and Johnston, C. M. (1994) Methods Mol. Biol. 22, 137-150[Medline] [Order article via Infotrieve]


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?



This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/17/15013    most recent
M201005200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schüttelkopf, A. W.
Right arrow Articles by Hunter, W. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schüttelkopf, A. W.
Right arrow Articles by Hunter, W. N.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.